Smith & Nephew SNATS Total Liabilities 2010-2025 | SNN
Smith & Nephew SNATS total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Smith & Nephew SNATS total liabilities for the quarter ending June 30, 2025 were $5.089B, a 8.12% increase year-over-year.
- Smith & Nephew SNATS total liabilities for 2024 were $5.089B, a 6.69% increase from 2023.
- Smith & Nephew SNATS total liabilities for 2023 were $4.77B, a 1.34% increase from 2022.
- Smith & Nephew SNATS total liabilities for 2022 were $4.707B, a 12.05% decline from 2021.
| Smith & Nephew SNATS Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $5,089 |
| 2023 | $4,770 |
| 2022 | $4,707 |
| 2021 | $5,352 |
| 2020 | $5,733 |
| 2019 | $4,158 |
| 2018 | $3,185 |
| 2017 | $3,222 |
| 2016 | $3,386 |
| 2015 | $3,201 |
| 2014 | $3,266 |
| 2013 | $1,772 |
| 2012 | $1,758 |
| 2011 | $1,560 |
| 2010 | $1,960 |
| 2009 | $2,386 |
| Smith & Nephew SNATS Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $5,089 |
| 2024-06-30 | $5,337 |
| 2023-12-31 | $4,770 |
| 2023-06-30 | $4,611 |
| 2022-12-31 | $4,707 |
| 2022-06-30 | $4,710 |
| 2021-12-31 | $5,352 |
| 2021-06-30 | $5,602 |
| 2020-12-31 | $5,733 |
| 2020-06-30 | $4,579 |
| 2019-12-31 | $4,158 |
| 2019-06-30 | $3,994 |
| 2018-12-31 | $3,185 |
| 2018-06-30 | $3,070 |
| 2017-12-31 | $3,222 |
| 2017-06-30 | $3,238 |
| 2016-12-31 | $3,386 |
| 2015-12-31 | $3,201 |
| 2015-06-30 | $3,166 |
| 2014-12-31 | $3,266 |
| 2014-09-30 | $3,633 |
| 2014-06-30 | $3,587 |
| 2014-03-31 | $1,724 |
| 2013-12-31 | $1,772 |
| 2013-09-30 | $1,656 |
| 2013-06-30 | $1,557 |
| 2013-03-31 | $1,512 |
| 2012-12-31 | $1,758 |
| 2012-09-30 | $1,355 |
| 2012-06-30 | $1,255 |
| 2012-03-31 | $1,431 |
| 2011-12-31 | $1,560 |
| 2011-09-30 | $1,764 |
| 2011-06-30 | $1,776 |
| 2011-03-31 | $1,787 |
| 2010-12-31 | $1,960 |
| 2010-09-30 | $2,400 |
| 2010-06-30 | $2,273 |
| 2010-03-31 | $2,309 |
| 2009-12-31 | $2,386 |
| 2009-09-30 | $2,618 |
| 2009-06-30 | $2,638 |
| 2009-03-31 | $2,598 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $16.271B | $5.810B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.514B | 26.91 |
| Boston Scientific (BSX) | United States | $155.747B | 37.14 |
| Stryker (SYK) | United States | $149.436B | 30.42 |
| EssilorLuxottica (ESLOY) | France | $144.168B | 0.00 |
| Medtronic (MDT) | Ireland | $117.977B | 16.64 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.715B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.412B | 24.82 |
| ResMed (RMD) | United States | $41.845B | 29.93 |
| GE HealthCare Technologies (GEHC) | United States | $34.055B | 16.01 |
| Agilent Technologies (A) | United States | $33.846B | 22.07 |
| Koninklijke Philips (PHG) | Netherlands | $26.577B | 17.58 |
| Terumo (TRUMY) | Japan | $26.206B | 31.05 |
| Insulet (PODD) | United States | $23.159B | 77.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.260B | 13.53 |
| Baxter (BAX) | United States | $12.615B | 9.75 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.048B | 29.56 |
| Lantheus Holdings (LNTH) | United States | $3.819B | 10.32 |
| Envista Holdings (NVST) | United States | $3.510B | 24.56 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.272B | 8.17 |
| Prestige Consumer Healthcare (PBH) | United States | $3.231B | 14.34 |
| ICU Medical (ICUI) | United States | $3.106B | 21.15 |
| Haemonetics (HAE) | United States | $2.661B | 11.88 |
| LeMaitre Vascular (LMAT) | United States | $2.209B | 47.38 |
| Acuren (TIC) | United States | $2.126B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.005B | 0.00 |
| AtriCure (ATRC) | United States | $1.881B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.877B | 11.82 |
| Green Thumb Industries (GTBIF) | United States | $1.869B | 80.25 |
| Tilray Brands (TLRY) | Canada | $1.530B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.295B | 16.55 |
| AdaptHealth (AHCO) | United States | $1.249B | 17.75 |
| BioLife Solutions (BLFS) | United States | $1.229B | 2565.00 |
| Neogen (NEOG) | United States | $1.216B | 19.31 |
| InMode (INMD) | Israel | $0.921B | 8.52 |
| Kestra Medical Technologies (KMTS) | United States | $0.910B | 0.00 |
| Valneva SE (VALN) | France | $0.802B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.648B | 0.00 |
| SNDL (SNDL) | Canada | $0.631B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.613B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.593B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.61 |
| Surmodics (SRDX) | United States | $0.505B | 0.00 |
| Evolus (EOLS) | United States | $0.481B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.473B | 16.29 |
| CeriBell (CBLL) | United States | $0.419B | 0.00 |
| Owens & Minor (OMI) | United States | $0.396B | 3.51 |
| Sanuwave Health (SNWV) | United States | $0.366B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.345B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.302B | 0.00 |
| Omeros (OMER) | United States | $0.296B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.295B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| Brainsway (BWAY) | Israel | $0.290B | 59.08 |
| High Tide (HITI) | Canada | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 20.85 |
| TriSalus Life Sciences (TLSI) | United States | $0.246B | 0.00 |
| Cerus (CERS) | United States | $0.245B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.243B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| Organigram Global (OGI) | Canada | $0.219B | 0.00 |
| Quanterix (QTRX) | United States | $0.217B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.193B | 16.13 |
| FitLife Brands (FTLF) | United States | $0.171B | 21.05 |
| Biote (BTMD) | United States | $0.160B | 5.30 |
| Jushi Holdings (JUSHF) | United States | $0.142B | 0.00 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
| MacroGenics (MGNX) | United States | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 12.31 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.078B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.066B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 32.03 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.051B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 34.92 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.36 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Sharps Technology (STSS) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |